Most sold healthcare stocks in Q2 2024
See which Healthcare stocks institutional investors trimmed or exited the most in Q2 2024, measured as net reductions in reported share positions from Q1 2024 into Q2 2024. Notable reductions at the top of this list include TELADOC HEALTH INC (TDOC), THE CIGNA GROUP (CI), EXACT SCIENCES CORP (EXAS), DANAHER CORP (DHR). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| TDOC | TELADOC HEALTH INC | -8,623,508 | -$116.86M | 0 | 2 | 4 | 0 | 6 |
| CI | THE CIGNA GROUP | -4,309,372 | -$1.98B | 1 | 3 | 7 | 1 | 14 |
| EXAS | EXACT SCIENCES CORP | -3,414,723 | -$194.26M | 1 | 2 | 4 | 0 | 7 |
| DHR | DANAHER CORP | -3,393,215 | -$846.47M | 1 | 6 | 5 | 2 | 19 |
| VERV | VERVE THERAPEUTICS INC | -2,829,240 | -$63.58M | 0 | 1 | 1 | 0 | 2 |
| VSTM | VERASTEM INC | -2,481,357 | -$28.98M | 0 | 0 | 0 | 2 | 0 |
| TMO | THERMO FISHER SCIENTIFIC INC | -1,985,512 | -$1.36B | 1 | 8 | 8 | 3 | 21 |
| NVO | NOVO-NORDISK A/S-SPONS ADR | -1,964,792 | $1.39B | 2 | 4 | 3 | 2 | 12 |
| SGRY | SURGERY PARTNERS INC | -1,949,041 | -$77.41M | 0 | 0 | 2 | 1 | 2 |
| BSX | BOSTON SCIENTIFIC CORP | -1,934,878 | -$102.07M | 0 | 3 | 6 | 1 | 10 |
| EWTX | EDGEWISE THERAPEUTICS INC | -1,903,400 | -$34.23M | 0 | 0 | 1 | 1 | 1 |
| CERS | CERUS CORP | -1,704,812 | -$5.33M | 0 | 0 | 2 | 0 | 2 |
| WBA | WALGREENS BOOTS ALLIANCE INC | -1,680,979 | -$31.37M | 0 | 4 | 2 | 1 | 6 |
| BLUE | BLUEBIRD BIO INC | -1,417,023 | $687.72K | 0 | 1 | 2 | 0 | 4 |
| CYH | COMMUNITY HEALTH SYSTEMS INC | -1,373,621 | -$4.00M | 0 | 1 | 0 | 1 | 1 |
| GEHC | GE HEALTHCARE TECHNOLOGY | -1,327,335 | -$450.65M | 0 | 8 | 2 | 2 | 14 |
| NKTR | NEKTAR THERAPEUTICS | -1,306,848 | $4.11M | 0 | 0 | 1 | 0 | 2 |
| ALGN | ALIGN TECHNOLOGY INC | -1,289,671 | -$607.49M | 2 | 4 | 6 | 1 | 14 |
| AGL | AGILON HEALTH INC | -1,267,286 | -$5.96M | 0 | 0 | 2 | 2 | 3 |
| A | AGILENT TECHNOLOGIES INC | -1,163,812 | $36.60M | 0 | 3 | 4 | 1 | 9 |
| OPK | OPKO HEALTH INC | -1,093,453 | $354.27K | 0 | 0 | 1 | 0 | 1 |
| ARAY | ACCURAY INC | -962,008 | $2.72M | 0 | 1 | 0 | 1 | 1 |
| AQST | AQUESTIVE THERAPEUTICS INC | -879,600 | $1.28M | 0 | 0 | 1 | 0 | 1 |
| ELAN | ELANCO ANIMAL HEALTH INC | -858,997 | -$169.17M | 1 | 0 | 3 | 0 | 4 |
| TWST | TWIST BIOSCIENCE CORP | -850,210 | $63.81M | 0 | 0 | 1 | 1 | 2 |
| EDIT | EDITAS MEDICINE INC | -799,824 | $453.77K | 1 | 0 | 1 | 0 | 2 |
| INCY | INCYTE CORP | -798,081 | $354.77M | 0 | 3 | 5 | 1 | 9 |
| QIPT | QUIPT HOME MEDICAL CORP | -776,930 | -$2.35M | 0 | 0 | 1 | 1 | 1 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | -767,161 | -$124.74M | 0 | 2 | 5 | 2 | 8 |
| AZN | ASTRAZENECA PLC-SPONS ADR | -756,819 | $2.72M | 1 | 3 | 4 | 1 | 8 |
| ACRS | ACLARIS THERAPEUTICS INC | -751,200 | $1.01M | 0 | 0 | 1 | 0 | 2 |
| BHC | BAUSCH HEALTH COS INC | -751,116 | -$139.16M | 0 | 1 | 2 | 2 | 5 |
| EBS | EMERGENT BIOSOLUTIONS INC | -717,553 | $1.18M | 0 | 0 | 1 | 0 | 1 |
| TVTX | TRAVERE THERAPEUTICS INC | -658,200 | $18.09M | 0 | 0 | 1 | 0 | 1 |
| NVS | NOVARTIS AG-SPONSORED ADR | -657,347 | $366.46M | 0 | 3 | 4 | 2 | 7 |
| SNY | SANOFI-ADR | -646,560 | -$37.69M | 1 | 4 | 4 | 0 | 10 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | -630,200 | $5.93M | 0 | 0 | 1 | 0 | 1 |
| LAB | STANDARD BIOTOOLS INC | -612,349 | -$66.26M | 0 | 0 | 2 | 0 | 3 |
| ESPR | ESPERION THERAPEUTICS INC | -594,600 | $3.29M | 0 | 1 | 1 | 0 | 2 |
| EXEL | EXELIXIS INC | -586,125 | $324.92M | 0 | 4 | 1 | 1 | 5 |
| ME | 23ANDME HOLDING CO -CLASS A | -571,382 | $1.67M | 1 | 0 | 1 | 0 | 2 |
| KZR | KEZAR LIFE SCIENCES INC | -559,600 | $465.88K | 0 | 0 | 1 | 0 | 1 |
| BEAM | BEAM THERAPEUTICS INC | -549,930 | -$91.52M | 0 | 1 | 1 | 0 | 2 |
| PINC | PREMIER INC-CLASS A | -549,829 | $106.27K | 0 | 0 | 1 | 1 | 1 |
| TGTX | TG THERAPEUTICS INC | -531,996 | $6.25M | 0 | 0 | 3 | 0 | 5 |
| HCAT | HEALTH CATALYST INC | -502,200 | -$3.30M | 0 | 0 | 1 | 1 | 2 |
| MRK | MERCK & CO. INC. | -499,797 | -$89.87M | 2 | 10 | 13 | 1 | 29 |
| IMUX | IMMUNIC INC | -456,184 | $322.12K | 0 | 0 | 1 | 0 | 1 |
| OM | OUTSET MEDICAL INC | -452,388 | -$1.00K | 0 | 0 | 0 | 1 | 0 |
| JNJ | JOHNSON & JOHNSON | -445,647 | $64.31M | 1 | 7 | 16 | 0 | 30 |
Frequently asked questions about Most sold healthcare stocks in Q2 2024
What are the most sold Healthcare stocks in Q2 2024?
The most sold healthcare stocks in Q2 2024 are those with the largest decrease in reported share counts across institutional investors compared to Q1 2024, based on SEC 13F filings.
Which healthcare stocks did institutional investors trimmed or exited the most in Q2 2024?
Among filers in this sector, net reductions were largest in companies such as TELADOC HEALTH INC (TDOC), THE CIGNA GROUP (CI), EXACT SCIENCES CORP (EXAS), based on aggregated 13F data.
How is institutional selling calculated?
Selling is calculated by summing the net decrease in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q1 2024).
Does this include all institutional owners?
Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.